Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes

Table 1

Baseline characteristics of patients with and without T2D infected with COVID-19.

Variables	NDM group ()	T2D group ()	value
Age (year)
Age median (IQR), years	59.70 (30-86)	60.45 (38-88)	0.83
Sex
Female, (%)	21/40 (52.50%)	21/40 (52.50%)	1.00
Clinical classification
Mild type, (%)	80/164 (48.78%)	12/40 (30.00%)	0.03
Moderate type, (%)	71/164 (43.29%)	18/40 (45.00%)	0.84
Severe cases, (%)	12/164 (7.31%)	9/40 (22.50%)	0.01
Critically ill type, (%)	1/164 (0.60%)	1/40 (2.50%)	≤0.001
Comorbidities at admission
Cardiovascular and cerebrovascular, (%)	18/40 (45.00%)	20/40 (50.00%)	0.65
Digestive system disease, (%)	2/40 (5.00%)	1/40 (2.50%)	0.91
Respiratory system diseases, (%)	3/40 (0.75%)	2/40 (5.00%)	0.98
Nervous system diseases, (%)	1/40 (2.50%)	1/40 (2.50%)	1.00
Malignant tumor, (%)	0/40 (0.00%)	1/40 (2.50%)	0.91
Chronic kidney disease, (%)	6/40 (15.00%)	5/40 (12.50%)	0.56
Chronic liver disease, (%)	1/40 (2.50%)	1/40 (2.50%)	1.00
Chronic obstructive pulmonary disease, (%)	1/40 (2.50%)	1/40 (2.50%)	1.00
HIV infection, (%)	0/40 (0.00%)	0/40 (0.00%)	1.00

values indicate differences between T2D patients and NDM patients. was considered statistically significant.